Unscheduled Hospital Readmission After Crenel Lateral Interbody Fusion

Completed

• Conditions: Spine Degeneration
• Interventions: Procedure: Crenel lateral interbody fusion plus second stage surgery; Procedure: Crenel Lateral Interbody Fusion

• Registration Number: NCT06614296
• Lead Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Brief Summary

The goal of this observational study is to learn about the readmission related to Crenel Lateral Interbody Fusion (CLIF). The main question it aims to answer is:

What are the risk factors for readmission after CLIF surgery?

Detailed Description

Not available

Study Timeline

• Study Start: 2024-04-03
• Primary Completion: 2024-07-25
• Study Completion: 2024-08-02
• Status Verified: 2024-09
• Study First Submitted: 2024-09-24
• Study First Submitted QC: 2024-09-24
• Study First Posted: 2024-09-26
• Last Update Submitted: 2024-09-27
• Last Update Posted: 2024-09-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Patients with spinal degeneration undergoing CLIF surgery

Exclusion Criteria

• Under the age of 18

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Unscheduled readimission	Crenel lateral interbody fusion plus second stage surgery	Unscheduled readimission after CLIF
Scheduled readimission	Crenel Lateral Interbody Fusion	Scheduled readimission after CLIF

Primary Outcome Measures

Name	Time	Method
Unscheduled readmission	1 year	Unscheduled readmission refers to a patient who was unplanned or unexpected return to the hospital after CLIF discharged from a previous hospitalization.

Trial Locations

Locations (1)

2nd Affiliated Hospital, School of Medicine, Zhejiang University; 🇨🇳 Hangzhou, Zhejiang, China